15 results
8-K
EX-1.2
GOSS
Gossamer Bio Inc
21 May 20
Gossamer Bio Announces Proposed Concurrent Public Offerings of Common Stock and Convertible Senior Notes due 2027
4:06pm
not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect.
(xliii)Cybersecurity; Data Protection. (A) There has been
8-K
EX-1.1
GOSS
Gossamer Bio Inc
21 May 20
Gossamer Bio Announces Proposed Concurrent Public Offerings of Common Stock and Convertible Senior Notes due 2027
4:06pm
would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect.
(xli)Cybersecurity; Data Protection
10-K
iur5nbe0
22 Mar 19
Annual report
4:45pm
424B4
fxmcpunop2sip0
8 Feb 19
Prospectus supplement with pricing info
4:40pm
S-1/A
EX-1.1
0mc4qbso
23 Jan 19
IPO registration (amended)
4:39pm
S-1/A
zarzk81 efr7
23 Jan 19
IPO registration (amended)
4:39pm
S-1
qhdofza
21 Dec 18
IPO registration
4:39pm
DRS/A
zvmd6gwk20xvon
29 Nov 18
Draft registration statement (amended)
12:00am
DRS
qhc78e kwdhk42dlfs
11 Oct 18
Draft registration statement
12:00am
- Prev
- 1
- Next